10A NCAC 26E .0308       USE OF SYNTHETIC CANNABINOIDS IN SCHEDULE II

Practitioners licensed pursuant to Chapter 90, Article 5, may dispense the following synthetic cannabinoids only as an antiemetic agent in cancer chemotherapy:

(1)           Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatine capsule in a U.S. Food and Drug Administration approved drug product; and

(2)           Nabilone.

 

History Note:        Authority G.S. 90‑90; 90‑100; 90‑101(h); 143B‑147;

Eff. December 1, 1986;

Amended Eff. December 1, 1987;

Pursuant to G.S. 150B-21.3A, rule is necessary without substantive public interest Eff. February 2, 2016.